AVITA Medical Inc
NASDAQ:RCEL
Income Statement
Earnings Waterfall
AVITA Medical Inc
Income Statement
AVITA Medical Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
5
|
5
|
5
|
5
|
5
|
|
| Revenue |
29
N/A
|
31
+7%
|
14
-55%
|
32
+128%
|
30
-6%
|
32
+7%
|
34
+8%
|
37
+9%
|
41
+9%
|
45
+11%
|
50
+10%
|
51
+1%
|
54
+7%
|
60
+11%
|
64
+7%
|
72
+12%
|
75
+4%
|
72
-3%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(6)
|
(6)
|
(2)
|
(6)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(11)
|
|
| Gross Profit |
24
N/A
|
25
+7%
|
12
-52%
|
26
+116%
|
25
-4%
|
27
+7%
|
29
+8%
|
32
+11%
|
34
+8%
|
38
+11%
|
43
+11%
|
43
+2%
|
47
+9%
|
52
+10%
|
56
+7%
|
62
+11%
|
64
+3%
|
61
-4%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(50)
|
(47)
|
(26)
|
(55)
|
(55)
|
(56)
|
(56)
|
(59)
|
(67)
|
(74)
|
(85)
|
(93)
|
(101)
|
(110)
|
(112)
|
(113)
|
(110)
|
(103)
|
|
| Selling, General & Administrative |
(37)
|
(34)
|
(19)
|
(41)
|
(43)
|
(44)
|
(45)
|
(48)
|
(53)
|
(59)
|
(66)
|
(72)
|
(80)
|
(88)
|
(91)
|
(91)
|
(88)
|
(83)
|
|
| Research & Development |
(15)
|
(15)
|
(8)
|
(15)
|
(14)
|
(15)
|
(14)
|
(15)
|
(17)
|
(17)
|
(21)
|
(21)
|
(21)
|
(22)
|
(20)
|
(21)
|
(22)
|
(20)
|
|
| Other Operating Expenses |
2
|
2
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(26)
N/A
|
(22)
+16%
|
(14)
+35%
|
(29)
-99%
|
(30)
-5%
|
(30)
+1%
|
(27)
+8%
|
(27)
-1%
|
(32)
-18%
|
(36)
-11%
|
(42)
-18%
|
(50)
-17%
|
(54)
-9%
|
(58)
-8%
|
(56)
+4%
|
(51)
+10%
|
(46)
+9%
|
(41)
+10%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
8
|
8
|
9
|
7
|
0
|
(1)
|
0
|
(1)
|
|
| Pre-Tax Income |
(27)
N/A
|
(22)
+16%
|
(14)
+35%
|
(29)
-98%
|
(30)
-5%
|
(30)
+1%
|
(27)
+11%
|
(26)
+1%
|
(30)
-16%
|
(34)
-10%
|
(35)
-5%
|
(45)
-27%
|
(50)
-11%
|
(57)
-15%
|
(62)
-8%
|
(57)
+8%
|
(52)
+10%
|
(49)
+6%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(27)
|
(22)
|
(14)
|
(29)
|
(30)
|
(30)
|
(27)
|
(26)
|
(31)
|
(34)
|
(35)
|
(45)
|
(50)
|
(57)
|
(62)
|
(57)
|
(52)
|
(49)
|
|
| Net Income (Common) |
(27)
N/A
|
(22)
+16%
|
(14)
+35%
|
(29)
-98%
|
(30)
-5%
|
(30)
+1%
|
(27)
+10%
|
(26)
+1%
|
(31)
-16%
|
(34)
-10%
|
(35)
-5%
|
(45)
-27%
|
(50)
-11%
|
(57)
-15%
|
(62)
-8%
|
(57)
+8%
|
(52)
+10%
|
(49)
+6%
|
|
| EPS (Diluted) |
-1.17
N/A
|
-0.89
+24%
|
-0.58
+35%
|
-1.15
-98%
|
-1.21
-5%
|
-1.19
+2%
|
-1.07
+10%
|
-1.05
+2%
|
-1.21
-15%
|
-1.33
-10%
|
-1.4
-5%
|
-1.76
-26%
|
-1.94
-10%
|
-2.2
-13%
|
-2.39
-9%
|
-2.19
+8%
|
-1.97
+10%
|
-1.71
+13%
|
|